STOCK TITAN

Olink to present at two upcoming investor conferences

(Neutral)
(Neutral)
Tags
conferences

Rhea-AI Summary

Olink Holding AB (Nasdaq: OLK) announced participation in two major virtual investor conferences. CEO Jon Heimer and CFO Oskar Hjelm will be featured in a fireside chat at the Goldman Sachs Eighteenth Annual European Medtech and Healthcare Services Conference on September 8 at 10:30 a.m. ET, followed by a discussion at the Morgan Stanley 19th Annual Global Healthcare Conference on September 10 at 8:00 a.m. ET. Live and archived webcasts of these events will be accessible on the company’s investor relations website.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – OLK

+4.34%
+4.34% Session move

In the trading session that priced this news, OLK gained 4.34%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

UPPSALA, Sweden, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced that Jon Heimer, CEO, and Oskar Hjelm, CFO, will participate in the following virtual investor conferences:

  • Goldman Sachs Eighteenth Annual European Medtech and Healthcare Services Conference
    Fireside chat on Wednesday, September 8th at 10:30 a.m. ET
  • Morgan Stanley 19th Annual Global Healthcare Conference
    Fireside chat on Friday, September 10th at 8:00 a.m. ET

Live and archived webcasts of the events will be available on the “Investors” section of the Company’s website at https://investors.olink.com/investor-relations.

About Olink Holding

Olink Holding AB (Nasdaq: OLK) is a company dedicated to accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients. Olink provides a platform of products and services which are deployed across major biopharmaceutical companies and leading clinical and academic institutions to deepen the understanding of real-time human biology and drive 21st century healthcare through actionable and impactful science. The company was founded in 2016 and is well established across Europe, North America and Asia. Olink is headquartered in Uppsala, Sweden.

Contacts
Media and Investor Relations
Olink Holding AB (publ), Stina Thorman, stina.thorman@olink.com, +46707187354


FAQ